Smith Scott Thomas
- SEC CIK
- 0001965550
In the past year, 2 open-market purchase filings worth $77.7K and no sales.
Current role at each company
- ASND Ascendis Pharma A/SEVP & Chief Financial Officeras of Jun 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $77.7K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$77.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Smith Scott Thomas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 (view filing) | Jun 2 | Same day | Smith Scott ThomasEVP & Chief Financial Officer | PPurchase | +100 | $219.00 | +$21.9K | +2.3%4.37K after | |
| Jun 1, 2026 (view filing) | May 29 | 3 days | Smith Scott ThomasEVP & Chief Financial Officer | PPurchase | +250 | $223.32 | +$55.8K | +6.2%4.27K after |